Related Experiment Video
Updated: May 5, 2026

Investigating Mast Cell Secretory Granules; from Biosynthesis to Exocytosis
Published on: January 26, 2015
ANXA2 regulates the behavior of SGC-7901 cells
Meng-Yao Sun1, Rui-Huan Xing, Xiao-Jie Gao
1The Lab of Tumor Molecular Cellular Biology, Shaanxi Normal University, Xi'an, Shaanxi,China
Abstract:
ANXA2, a member of the annexin family, is overexpressed and plays important roles in tumor development. However, the significance of ANXA2 expression in gastric carcinoma has not been clarified.To elucidate its roles in growth of gastric cancer, ANXA2 expression in SGC-7901 cells was inhibited with a designated siRNA, then cell proliferation, cell cycling, apoptosis and motility were determined by MTT assay, flow cytometry, Hoechst 33342 staining and wound healing assay, respectively. To further assess the behavior of ANXA2 deleted SGC- 7901 cells, changes of microstructures were observed under fluorescence microscopy, laser scanning confocal microscopy and electron microscopy. We found that inhibition of ANXA2 expression caused cell proliferation to decrease significantly with G1 arrest, motility to be reduced with changes in pseudopodia/filopodia structure and F-actin and β-tubulin expression, and apoptosis to be enhanced albeit without significance. At the same time, ANXA2 deletion resulted in fewer pseudopodia/filopodia, non-stained areas were increased, contact inhibition among cells reappeared, and expression of F-actin and β-tubulin was decreased, with induction of polymerized disassembled forms. Taken together, these data suggest that ANXA2 overexpression is important to maintain the malignancy of cancer cells, and this member of the annexin family has potential to be considered as a target for the gene therapy of gastric carcinoma.
Insights
Annexin A2 (ANXA2) overexpression drives gastric cancer malignancy. Inhibiting ANXA2 in gastric cancer cells reduced proliferation and motility, suggesting ANXA2 as a potential gene therapy target.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Annexin A2 (ANXA2) is implicated in tumor development.
- The specific role of ANXA2 in gastric carcinoma remains unclear.
Purpose of the Study:
- To investigate the function of ANXA2 in gastric cancer cell growth.
- To evaluate ANXA2 as a potential therapeutic target for gastric carcinoma.
Main Methods:
- ANXA2 expression was inhibited using siRNA in SGC-7901 gastric cancer cells.
- Cell proliferation, cell cycle, apoptosis, and motility were assessed using MTT assay, flow cytometry, Hoechst 33342 staining, and wound healing assays.
- Microstructural changes were observed via fluorescence microscopy, laser scanning confocal microscopy, and electron microscopy.
Main Results:
- ANXA2 inhibition significantly decreased cell proliferation and motility, inducing G1 arrest.
- Apoptosis was enhanced, though not significantly.
- ANXA2 deletion led to reduced pseudopodia/filopodia, decreased F-actin and β-tubulin expression, and reappearance of contact inhibition.
Conclusions:
- ANXA2 overexpression is crucial for maintaining gastric cancer cell malignancy.
- ANXA2 presents a potential target for gene therapy in gastric carcinoma.

